PPOKF yields 2.96% · JNJ yields 2.14%● Live data
📍 PPOKF pulled ahead of the other in Year 1
Combined, PPOKF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PPOKF + JNJ for your $10,000?
PT Charoen Pokphand Indonesia Tbk produces and sells poultry feed, processed chicken, and day old chicks (DOC) in Indonesia. The company offers broiler and layer poultry feed; and various poultry feed products for parent stock, duck, native chicken, fighting cock, and quail, as well as feed for cattle and swine under the brands of HI-PRO, HI-PRO-VITE, BINTANG, BONAVITE, ROYAL FEED, TURBO FEED, and TIJI. It also provides various types of DOC, such as broiler DOC; layer DOC; and other DOC, such as DOC for parent stock and male layer. In addition, the company sells various food products under the Golden Fiesta, Fiesta, Champ, and Okey brands. Further, it is involved in poultry farming and beverage activities; trading of processed food and medicine; the production of plastic packaging products; the production and distribution of raw material for feed; and the operation of restaurants and convenience stores. The company was formerly known as PT Charoen Pokphand Indonesia Animal Feedmill Co. Limited. PT Charoen Pokphand Indonesia Tbk was founded in 1972 and is headquartered in Jakarta, Indonesia. PT Charoen Pokphand Indonesia Tbk is a subsidiary of PT Charoen Pokphand Indonesia Group.
Full PPOKF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.